ImpA1CT

Revolutionizing Diabetes Care

ImpA1CT is a business line initiated by ProximityFocal company, to bring in Diabetes remission and Diabetes reversal Solutions to the middle east.

ImpA1CT is the new wave of evidence-based Diabetes Solutions.

Diabetes Remission Program

Program Details

Aiming to bring the patient into remission, back to the prediabetic state, stopping all diabetes medications.
3 months program
For newly diagnosed Diabetic Patients (less than 5 years)

Evidence-based Results

82% of patients went into remission.
Patients stop medications from Day 1
Patients going into remission and completely stopping the medications, while maintaining HA1C below 6.5%
Diabetes Reversal Program

Program Details

Aiming to improve diabetic patients quality of life, reduce medications, reduce cost.
3 months program
For Any Diabetic Patient (Including Type 1 and Type 2)

Evidence-based Results

21% stopped insulin
50-60% Reduction in medication
Annual Saving 44% on Diabetes-Related Cost
27% Saving of Total Health Care Cost

How it Works

1

Monitoring the progress remotely

2

Daily interactions via phone and messages

3

Weekly group sessions

4

One-on-one sessions

Publications

Results are incorporated in the ADA Standards of Medical Care in Diabetes

Sustaining weight loss can be challenging but has long-term benefits; maintaining weight loss for 

5 years is associated with sustained improvements in A1C and lipid levels

PLATFORM

Delivering impA1Ct  through ProximityFocal’s online platform to scale evidence-based and value-based precision medicine.

© ProximityFocal 2024. All rights reserved.

Developed by Motawreen agency